Joint (NASDAQ:JYNT) Price Target Cut to $18.00 by Analysts at B. Riley

Key Points

• B. Riley has reduced its price target for Joint (NASDAQ:JYNT) from $20.00 to $18.00, while still maintaining a "buy" rating, suggesting a potential upside of 67.91% from the current stock price.
• Joint's stock opened at $10.72 and has a market capitalization of $164.02 million, with a price-to-earnings ratio of -19.40 and a recent buyback plan authorized for up to $5 million in shares.
• Significant institutional interest has been noted, with 76.88% of the company's stock owned by institutional investors, highlighting a notable increase in holdings from firms like Nisa Investment Advisors and Wells Fargo.

Joint (NASDAQ:JYNT - Get Free Report) had its price objective cut by equities researchers at B. Riley from $20.00 to $18.00 in a report released on Friday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. B. Riley's price objective indicates a potential upside of 67.60% from the company's current price. B. Riley also issued estimates for Joint's Q4 2025 earnings at $0.16 EPS, FY2026 earnings at $0.52 EPS and FY2027 earnings at $0.68 EPS.

Separately, Lake Street Capital lowered their price objective on Joint from $20.00 to $16.00 and set a "buy" rating for the company in a research report on Friday, May 9th.

Joint Trading Up 0.4%

JYNT traded up $0.04 on Friday, hitting $10.74. The company had a trading volume of 54,106 shares, compared to its average volume of 43,802. The firm has a market cap of $164.35 million, a P/E ratio of -32.55 and a beta of 1.53. Joint has a 1 year low of $9.58 and a 1 year high of $13.47. The company's fifty day moving average price is $11.47 and its 200 day moving average price is $11.11.

Joint (NASDAQ:JYNT - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. The company had revenue of $13.27 million for the quarter, compared to analyst estimates of $13.32 million. Joint had a negative net margin of 7.02% and a positive return on equity of 0.67%. On average, analysts predict that Joint will post 0.11 earnings per share for the current year.

Joint declared that its Board of Directors has approved a share buyback program on Thursday, June 5th that authorizes the company to buyback $5.00 million in shares. This buyback authorization authorizes the company to purchase up to 2.7% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's board believes its stock is undervalued.

Hedge Funds Weigh In On Joint

Institutional investors and hedge funds have recently made changes to their positions in the stock. Nisa Investment Advisors LLC boosted its holdings in Joint by 5,141.9% in the second quarter. Nisa Investment Advisors LLC now owns 2,254 shares of the company's stock valued at $26,000 after purchasing an additional 2,211 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in Joint by 51.7% in the fourth quarter. Wells Fargo & Company MN now owns 5,088 shares of the company's stock valued at $54,000 after purchasing an additional 1,735 shares in the last quarter. MetLife Investment Management LLC acquired a new position in Joint in the first quarter valued at approximately $88,000. Sanders Morris Harris LLC acquired a new position in Joint in the second quarter valued at approximately $145,000. Finally, BNP Paribas Financial Markets boosted its holdings in Joint by 6.8% in the fourth quarter. BNP Paribas Financial Markets now owns 24,031 shares of the company's stock valued at $255,000 after purchasing an additional 1,521 shares in the last quarter. 76.88% of the stock is owned by institutional investors and hedge funds.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.